Universal Health Services, Inc. (UHS) Stock Price & How to Invest
Last updated November 2026
Short answer
Universal Health Services (UHS) is one of the largest US hospital operators, running acute care hospitals and behavioral health facilities, and its stock trades at a high-single-digit earnings multiple (about 7.5 times trailing earnings at ~$179 on November 20, 2026) that reflects both steady growth and policy or reimbursement uncertainty. Investors typically access it by buying shares on the NYSE under the ticker UHS or through healthcare and broad-market index funds that hold it.
UHS stock price
As of 2026-11-20, Universal Health Services, Inc. (UHS) last closed at $179.43, down 22.6% over the past year. Over the past 52 weeks it has traded between $141.17 and $244.18.
Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Universal Health Services, Inc.'s investor relations page. Walnut is informational, not investment advice.
UHS key stats
At $179.43 on November 20, 2026, Universal Health Services, Inc. (UHS) has a market cap of $10.3B, a P/E of 7.5 on trailing earnings (7.8 on forward earnings) and a dividend yield of 0.45%.
- Market cap
- $10.3B
- P/E (trailing)
- 7.5
- P/E (forward)
- 7.8
- EPS (trailing 12 months)
- $23.90
- Price to book
- 1.4
- Dividend yield
- 0.45%
- Beta
- 1.11
Market cap, P/E and yield are measured at the $179.43 price on November 20, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.
What's new with Universal Health Services, Inc. (UHS)?
The last two weeks for Universal Health Services, Inc., as of November 22, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.
- UHS closed at $179.43 on November 20, 2026, down 7.5% over the past five trading days (from $194.07).
- On November 11, 2026, RBC Capital raised its target to $207.00 from $183.00 (Sector Perform).
Universal Health Services, Inc. filed no current, quarterly or annual report with the SEC in the last two weeks.
Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.
Universal Health Services, Inc. (UHS) latest quarter
Universal Health Services reported revenue of $4.7 billion for Q3 2026, up 5% from a year earlier (Universal Health Services, Oct 27, 2026).
Source: Universal Health Services Q3 2026 results, Oct 27, 2026. Full earnings breakdown
What does Universal Health Services, Inc. (UHS) do?
Universal Health Services is a Pennsylvania-based healthcare company that owns and operates acute care hospitals, behavioral health facilities, outpatient centers, and ambulatory surgery locations across the United States and in the United Kingdom. Its two core segments are acute care, which covers general hospitals and emergency and surgical services, and behavioral health, which spans inpatient psychiatric and addiction treatment facilities where UHS is one of the largest operators in the country. The company also expanded its virtual behavioral health reach through the acquisition of Talkspace, and in November 2026 coverage focused on its growing outpatient behavioral health footprint.
The investment picture centers on scale and steady demand. UHS generated net revenues of roughly $17.4 billion in full-year 2025, up about 9.7 percent year over year, with net income attributable to UHS near $1.49 billion. Growth has continued through 2026 at a slower pace: quarterly net revenue went from about $4.5 billion in the first quarter to about $4.64 billion in the second and about $4.73 billion in the third, which was up roughly 5.3 percent year over year. Trailing twelve-month revenue reached about $18.35 billion, with net income of about $1.46 billion. Third-quarter net income attributable to UHS was about $309 million, below the prior two quarters, and trailing earnings growth turned negative at about -10.9 percent. The stock has often carried a low earnings multiple because investors weigh Medicaid and Medicare reimbursement changes, labor cost pressure, and healthcare policy risk against the operating results.
The share price has been volatile. As of November 20, 2026 UHS closed at about $178.95, down about 18.6 percent year to date and 20.6 percent over one year, inside a 52-week range of roughly $140 to $246. At that price the company is valued near $10.3 billion. Hospital stocks rallied in early November after Democrats won control of Congress in the midterm elections, a result traders read as easing pressure on Medicaid funding, though commentary also flagged lower Medicaid supplemental payments for UHS in 2027. The next quarterly report, for the fourth quarter, is expected in early 2027.
What's driving Universal Health Services, Inc. (UHS)?
1. Behavioral health scale
UHS is one of the largest operators of inpatient behavioral health facilities in the United States, a segment with persistent demand and fewer large competitors than acute care. Same-store growth and admissions trends in this segment are a key driver, and the Talkspace acquisition adds a virtual care channel. The company has also been adding outpatient behavioral health locations, which extends its reach beyond inpatient beds.
2. Acute care volumes and pricing
The acute care segment benefits from patient volume recovery, surgical and emergency demand, and negotiated rate increases with payers. Adjusted admissions and revenue per adjusted admission are watched closely as indicators of underlying hospital demand, and the mix of Medicaid patients matters more as supplemental payment programs change.
3. Margin and cost control
After years of elevated contract labor and wage pressure, UHS has worked to normalize staffing costs, which supports EBITDA margins. The operating margin over the trailing year was about 10.9 percent and the profit margin about 8 percent. Results against estimates have been close all year: first-quarter EPS of about $5.62 beat the ~$5.46 consensus, second-quarter EPS of about $5.98 was in line with ~$6.01, and third-quarter EPS of about $5.22 came in slightly above ~$5.15.
4. Capital returns
UHS regularly repurchases Class B shares and pays a modest quarterly dividend, returning capital while reinvesting in facilities. In the first quarter of 2026 it bought back roughly 675,000 shares for about $127 million, and on November 18, 2026 it declared its next quarterly dividend, keeping the annual rate near $0.80.
What are the risks to Universal Health Services, Inc. (UHS)?
The largest risks are tied to government reimbursement. A meaningful share of UHS revenue comes from Medicare and Medicaid, so changes to those programs, state Medicaid supplemental payment structures, or federal healthcare policy can move earnings materially. Reporting in November 2026 pointed to lower Medicaid supplemental payments in 2027. Labor costs, including nursing wages and contract labor, remain a swing factor for margins. The behavioral health segment carries regulatory, staffing, and reputational scrutiny given the nature of inpatient psychiatric care. Rising interest expense on debt and integration risk from acquisitions such as Talkspace add further uncertainty. Analysts expect fourth-quarter EPS of about $5.61, down roughly 4.7 percent from a year earlier, and full-year 2027 EPS of about $23.03, only slightly above 2026. Free cash flow of about $745 million over the trailing year was about half of net income, and debt stood near $6.2 billion against about $169 million of cash.
What is the Universal Health Services, Inc. (UHS) forecast?
17 analysts publish price targets on UHS, averaging $196.71 as of November 2026, or +9.6% against the $179.43 share price on November 20, 2026. The published targets run from $156.00 to $250.00, a moderate spread, and the ratings split 7 buy, 12 hold, 1 sell. Over the last six months there have been 4 raises and 6 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.
Read the full UHS forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.
Is UHS a buy or a sell?
We give no verdict on Universal Health Services, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.
The case for buying. Behavioral health scale. UHS is one of the largest operators of inpatient behavioral health facilities in the United States, a segment with persistent demand and fewer large competitors than acute care. The most optimistic published target, $250.00, assumes this works close to its best case.
The case against. The largest risks are tied to government reimbursement. The most pessimistic target, $156.00, is roughly what UHS is worth if this bites instead.
Read the full bull and bear case on UHS, including what would have to change to break either one. Walnut is not an investment adviser.
Has Universal Health Services, Inc. (UHS) split its stock?
No. Universal Health Services, Inc. (UHS) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.
How is Universal Health Services, Inc. (UHS) valued?
Market cap, P/E and dividend yield at today's price are in the UHS key stats above. The business figures below come from Universal Health Services, Inc.'s reported results as of November 2026 and change when it next reports.
- Revenue (TTM): ~$18.35B (Q3 2026 up ~5.3% YoY)
- Net income (TTM): ~$1.46B (profit margin ~8.0%)
- Q3 2026: Revenue ~$4.73B, EPS ~$5.22 vs ~$5.15 est.
- Total debt: ~$6.2B
As of November 2026: UHS trades at about 7.5 times trailing earnings and roughly 6.1 times EV/EBITDA, well below broader market averages, with a price-to-sales ratio near 0.56. The discount reflects caution around reimbursement and policy exposure and flat expected earnings for 2027, since revenue is still growing about 5 percent a year. The 17 covering analysts have a mean target near $197, and in November 2026 RBC raised its target to $207 and Mizuho to $225.
Who competes with Universal Health Services, Inc. (UHS)?
Acute care hospital operators
HCA Healthcare, Tenet Healthcare, and Community Health Systems compete in general acute care. HCA is by far the largest US hospital operator, giving it scale advantages in negotiating and purchasing, while Tenet has leaned into outpatient and ambulatory surgery and Community Health Systems focuses on rural and suburban markets.
Behavioral health providers
Acadia Healthcare is the closest pure-play competitor in inpatient behavioral health, competing directly with the UHS behavioral segment. Other regional psychiatric and addiction treatment operators and, increasingly, virtual behavioral health platforms also compete for patients and payer contracts.
What stocks are similar to Universal Health Services, Inc. (UHS)?
Other names that sit close to UHS: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.
How to invest in Universal Health Services, Inc. (UHS)
There are three common ways to get UHS exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so UHS sits alongside other stocks that express the same thesis.
Walnut takes the portfolio route. Describe a thesis where UHS fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.
New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.
The bottom line on Universal Health Services, Inc. (UHS)
UHS pairs consistent revenue growth across acute care and behavioral health with a valuation that stays modest because of reimbursement, labor, and policy risk, so the story is a large, profitable operator priced cautiously, not a growth name. Third-quarter 2026 revenue rose about 5.3% to roughly $4.73 billion and EPS of about $5.22 edged past the ~$5.15 consensus, yet the shares closed near $179 on November 20, 2026, down about 18.6% for the year and 20.6% over twelve months.
More on Universal Health Services, Inc. (UHS)
Whether UHS is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is UHS a buy or a sell?, and where the stock could go from here in the UHS stock forecast.
For income investors, whether UHS pays a dividend and how the payout looks is covered in does UHS pay a dividend? And to weigh UHS against a peer, read the full side-by-side comparisons: UHS vs HCA and UHS vs THC.
Wondering how UHS fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Universal Health Services, Inc.
Ask Walnut's AI anything about UHS and see how it fits what you own.
FAQ
What does Universal Health Services do?
+
UHS owns and operates acute care hospitals, behavioral health facilities, outpatient centers, and ambulatory surgery locations, mainly in the United States with some operations in the United Kingdom. Its two reporting segments are acute care and behavioral health.
How big is UHS by revenue?
+
UHS reported net revenues of roughly $17.4 billion in full-year 2025, up about 9.7 percent from the prior year. Quarterly net revenue in 2026 was about $4.5 billion in the first quarter, $4.64 billion in the second and $4.73 billion in the third, and trailing twelve-month revenue reached about $18.35 billion by September 2026. Analysts expect about $18.6 billion for full-year 2026.
Why is the UHS P/E ratio so low?
+
UHS often trades in the high single digits on a price-to-earnings basis, well below the broad market. This tends to reflect investor caution about Medicare and Medicaid reimbursement, healthcare policy, and labor costs, along with expectations of roughly flat earnings into 2027. As of November 20, 2026 it traded near 7.5 times trailing earnings of about $23.89 per share and about 7.8 times forward earnings.
Does UHS pay a dividend?
+
Yes, UHS pays a modest quarterly dividend of about $0.20 per share, for an annual rate near $0.80 and a yield around 0.5 percent at the November 2026 price. It declared its latest dividend on November 18, 2026. The payout is only about 3 percent of earnings, and the company also returns capital through Class B share repurchases.
Who are the main competitors of UHS?
+
In acute care, UHS competes with HCA Healthcare, Tenet Healthcare, and Community Health Systems. In behavioral health, its closest pure-play rival is Acadia Healthcare, along with regional psychiatric operators and virtual behavioral health platforms.
What are the biggest risks for UHS?
+
The largest risks are reimbursement and policy related, since much of UHS revenue comes from Medicare and Medicaid, and lower Medicaid supplemental payments are expected in 2027. Labor costs, regulatory scrutiny of behavioral health facilities, interest expense on about $6.2 billion of debt, and acquisition integration are additional factors that can affect earnings.
How can I invest in UHS?
+
UHS trades on the New York Stock Exchange under the ticker UHS. Investors can buy shares directly through a brokerage account or gain exposure through healthcare sector funds and broad US equity index funds that hold the stock.
How did UHS perform in its most recent quarter?
+
In the third quarter of 2026, UHS reported net revenue of about $4.73 billion, up roughly 5.3 percent year over year, with net income attributable to UHS near $309 million and EPS of about $5.22, slightly above the roughly $5.15 consensus. Net income was lower than the about $358 million earned in the second quarter. For the fourth quarter, analysts expect EPS of about $5.61 on revenue of about $4.76 billion.
How has UHS stock performed in 2026?
+
As of November 20, 2026 UHS closed at about $178.95, down about 18.6 percent year to date and 20.6 percent over one year, though up about 1.8 percent over three months. Its 52-week range is roughly $140 to $246, and analysts' mean price target is about $197.
How did the 2026 midterm elections affect UHS stock?
+
Hospital operators and health insurers rallied on November 4, 2026 after Democrats won control of Congress, as traders read the result as lowering the odds of further federal Medicaid cuts. UHS still finished the following weeks down about 4 percent over one month, and lower Medicaid payments are still expected for the company in 2027.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Universal Health Services, Inc.'s investor relations page or your broker before making investment decisions.